期刊文献+
共找到27篇文章
< 1 2 >
每页显示 20 50 100
Comparative analysis of conventional ultrasound and shear wave elastography features in primary breast diffuse large B-cell lymphoma
1
作者 Xiao-Duan Zhang Kai Zhang 《World Journal of Clinical Cases》 SCIE 2023年第33期7994-8002,共9页
BACKGROUND Primary breast diffuse large B-cell lymphoma(PB-DLBCL)is a rare subtype of non-Hodgkin lymphoma that accounts for<3%of extranodal lymphomas and 1%of breast tumors.Its diagnosis and management are challen... BACKGROUND Primary breast diffuse large B-cell lymphoma(PB-DLBCL)is a rare subtype of non-Hodgkin lymphoma that accounts for<3%of extranodal lymphomas and 1%of breast tumors.Its diagnosis and management are challenging because of its rarity,heterogeneity,and aggressive behavior.Conventional ultrasound(US)is the first-line imaging modality for breast lesions;however,it has limited specificity and accuracy for PB-DLBCL.Shear wave elastography(SWE)is a novel US technique that measures tissue stiffness and may reflect the histological characteristics and biological behavior of breast lesions.AIM To compare the conventional US and SWE features of PB-DLBCL and evaluate their diagnostic performance and prognostic value.METHODS We retrospectively reviewed the clinical data and US images of 32 patients with pathologically confirmed PB-DLBCL who underwent conventional US and SWE before treatment.We analyzed conventional US features(shape,margin,orientation,echo,posterior acoustic features,calcification,and vascularity)and SWE features(mean elasticity value,standard deviation,minimum elasticity value,maximum elasticity value,and lesion-to-fat ratio)of the PB-DLBCL lesions.Using receiver operating characteristic curve analysis,we determined the optimal cutoff values and diagnostic performance of conventional US and SWE features.We also performed a survival analysis to assess the prognostic value of conventional US and SWE features.RESULTS The results showed that the PB-DLBCL lesions were mostly irregular in shape(84.4%),microlobulated or spiculated in margins(75%),parallel in orientation(65.6%),hypoechoic in echo(87.5%),and had posterior acoustic enhancement(65.6%).Calcification was rare(6.3%)and vascularity was variable(31.3%avascular,37.5%hypovascular,and 31.3%hypervascular).The mean elasticity value of PB-DLBCL lesions was significantly higher than that of benign breast lesions(113.4±46.9 kPa vs 27.8±16.4 kPa,P<0.001).The optimal cutoff value of the mean elasticity for distinguishing PB-DLBCL from benign breast lesions was 54.5 kPa,with a sensitivity of 93.8%,specificity of 92.9%,positive predictive value of 93.8%,negative predictive value of 92.9%,and accuracy of 93.3%.The mean elasticity value was also significantly correlated with Ki-67 expression level(r=0.612,P<0.001),which is a marker of tumor proliferation and aggressiveness.Survival analysis showed that patients with higher mean elasticity values(>54.5 kPa)had worse overall survival(OS)and progression-free survival(PFS)than those with lower mean elasticity values(<54.5 kPa)(P=0.038 for OS and P=0.027 for PFS).CONCLUSION Conventional US and SWE provide useful information for diagnosing and forecasting PB-DLBCL.SWE excels in distinguishing PB-DLBCL from benign breast lesions,reflects tumor proliferation and aggressiveness,and improves disease management. 展开更多
关键词 primary breast diffuse large b-cell lymphoma Conventional ultrasound Shear wave elastography Diagnosis PROGNOSIS Tumor behavior
下载PDF
Helicobacter pylori eradication treatment for primary gastric diffuse large B-cell lymphoma:A single-center analysis
2
作者 Makoto Saito Akio Mori +7 位作者 Sayaka Kajikawa Emi Yokoyama Minoru Kanaya Koh Izumiyama Masanobu Morioka Takeshi Kondo Zen-Ichi Tanei Ai Shimizu 《World Journal of Clinical Cases》 SCIE 2023年第27期6424-6430,共7页
BACKGROUND Unlike the already established effect of Helicobacter pylori(H.pylori)eradication on gastric mucosa-associated lymphoid tissue(MALT)lymphoma,its therapeutic effect on primary gastric diffuse large B-cell ly... BACKGROUND Unlike the already established effect of Helicobacter pylori(H.pylori)eradication on gastric mucosa-associated lymphoid tissue(MALT)lymphoma,its therapeutic effect on primary gastric diffuse large B-cell lymphoma(DLBCL)is still unclear.AIM To clarify the efficacy of H.pylori eradication treatment for primary gastric DLBCL.METHODS We reported on 3 new cases,and added them to 3 previously reported cases.We analyzed the usefulness of H.pylori eradication treatment for gastric DLBCL for a total of 6 cases at our center.RESULTS Of the 6 patients(27-90 years old,3 males and 3 females),all 3 patients with single lesions(one transformed from MALT lymphoma)achieved complete remission(CR)after H.pylori eradication.Regarding the 2 newly reported cases,CR was maintained for more than 6 years with eradication treatment alone.In contrast,none of the 3 patients with 2 lesions achieved CR.In 1 newly reported case,endoscopic CR was achieved in one lesion,while stable disease was obtained in the other lesion.Two patients with progressive disease responded to standard chemo therapy±radiation and remained in CR for more than 6 years.CONCLUSION We believe it is worthwhile to attempt H.pylori eradication for elderly patients with primary gastric DLBCL in a single lesion with a small tumor burden. 展开更多
关键词 primary gastric diffuse large b-cell lymphoma TREATMENT Helicobacter pylori ERADICATION
下载PDF
Comprehensive treatment for primary right renal diffuse large B-cell lymphoma with a renal vein tumor thrombus:A case report
3
作者 Jun He Yi Mu +4 位作者 Bang-Wei Che Miao Liu Wen-Jun Zhang Sheng-Han Xu Kai-Fa Tang 《World Journal of Clinical Cases》 SCIE 2022年第16期5352-5358,共7页
BACKGROUND Renal involvement in lymphoma is commonly associated with widespread nodal or extranodal lymphoma.Primary renal diffuse large B-cell lymphoma is an extremely rare extranodal lymphoma,accounting for fewer th... BACKGROUND Renal involvement in lymphoma is commonly associated with widespread nodal or extranodal lymphoma.Primary renal diffuse large B-cell lymphoma is an extremely rare extranodal lymphoma,accounting for fewer than 1%of all renal masses.Interestingly,the patient in this study had a renal vein tumor thrombus that was observed after laparoscopic radical nephrectomy.CASE SUMMARY We report the case of a 56-year-old female patient with primary renal lymphoma and a renal vein tumor thrombus whose first symptom was right pain in the back and gross hematuria.Histopathology revealed primary renal diffuse large B-cell lymphoma.The patient received 8 standard cycles of rituximab with cyclophosphamide,doxorubicin,vincristine,and prednisone chemotherapy after surgery,and no obvious signs of recurrence were observed during the one-year follow-up.CONCLUSION We evaluated comprehensive treatment of primary renal diffuse large B-cell lymphoma and multidisciplinary management of this malignancy. 展开更多
关键词 primary renal lymphoma Renal diffuse large b-cell lymphoma Renal vein tumor thrombus DIAGNOSIS Comprehensive treatment Case report
下载PDF
Heterochronous multiple primary prostate cancer and lymphoma:A case report
4
作者 Jin-Long Liang Yu-Qing Bu +1 位作者 Li-Li Peng Hong-Zhen Zhang 《World Journal of Clinical Cases》 SCIE 2024年第7期1333-1338,共6页
BACKGROUND Multiple primary malignant tumors(MPMTs)are rare type of cancer,especially when solid tumors are the first and lymphoma is the second primary malignancy.We report a patient with heterochronous MPMTs consist... BACKGROUND Multiple primary malignant tumors(MPMTs)are rare type of cancer,especially when solid tumors are the first and lymphoma is the second primary malignancy.We report a patient with heterochronous MPMTs consisting of prostate cancer and rectal diffuse large B-cell lymphoma(DLBCL).CASE SUMMARY We report a 77-year-old male patient diagnosed with prostate cancer who was treated with radiation therapy and one year of endocrine therapy with bicalutamide(50 mg per day)and an extended-release implant of goserelin(1/28 d).Seven years later,rectal DLBCL with lung metastases was found.CONCLUSION Although rare,the possibility of prostate cancer combined with a double primary cancer of DLBCL can provide a deeper understanding. 展开更多
关键词 Multiple primary malignant tumors Radiation therapy Diffuse large b-cell lymphoma Prostate cancer Non-Hodgkin lymphoma Case report
下载PDF
Pancreatic T/histiocyte-rich large B-cell lymphoma: A case report and review of literature 被引量:8
5
作者 Shu-Mei Zheng De-Jiang Zhou +7 位作者 Yi-Hua Chen Rui Jiang Yun-Xia Wang Yong Zhang Hong-Li Xue Hai-Qiong Wang Dong Mou Wei-Zheng Zeng 《World Journal of Gastroenterology》 SCIE CAS 2017年第24期4467-4472,共6页
Primary pancreatic lymphoma(PPL)is an extremely rare form of extranodal malignant lymphoma.The most common histological subtype of PPL is diffuse large B cell lymphoma(DLBCL).In rare cases,PPL can also present as foll... Primary pancreatic lymphoma(PPL)is an extremely rare form of extranodal malignant lymphoma.The most common histological subtype of PPL is diffuse large B cell lymphoma(DLBCL).In rare cases,PPL can also present as follicular lymphoma,small lymphocytic lymphoma,and T cell lymphoma either of non-Hodgkin’s lymphoma or of Hodgkin’s lymphoma.T-cell/histiocyterich large B-cell lymphoma(T/HRBCL)is an uncommon morphologic variant of DLBCL with aggressive clinical course,it is predominantly a nodal disease,but extranodal sites such as bone marrow,liver,and spleen can be involved.Pancreatic involvement of T/HRBCL was not presented before.Herein,we report a 48-year-old male who was hospitalized with complaints of jaundice,dark brown urine,pale stools,and nausea.The radiological evaluation revealed a pancreatic head mass and,following operative biopsy,the tumor was diagnosed as T/HRBCL.The patient achieved remission after six cycles of CHOP chemotherapy.Therefore,T/HRBCL can be treated similarly to the stage-matched DLBCL and both of them get equivalent outcomes after chemotherapy. 展开更多
关键词 Non-Hodgkin's lymphoma T-cell/histiocyte-rich large b-cell lymphoma IMMUNOHISTOCHEMISTRY primary pancreatic lymphoma Diagnosis
下载PDF
Individualized Treatment and Palliative Care for A90-Year-Old Patient with Primary Gastric Diffuse Large-B Cell Lymphoma:4 Year Follow-up and Inspiration 被引量:1
6
作者 Yanjie Cao Jingqi Duan +4 位作者 Lifang Liu Xuan Wei Li Ren Lanning Zhang Wei Zhang 《Chinese Medical Sciences Journal》 CAS CSCD 2021年第1期72-77,共6页
A 90-year-old man was diagnosed with primary gastric diffuse large B-cell lymphoma(PGDLBL)by PET/CT examination,gastroscopy,biopsy and histopathological analysis at a regular physical check in April,2016.The patient r... A 90-year-old man was diagnosed with primary gastric diffuse large B-cell lymphoma(PGDLBL)by PET/CT examination,gastroscopy,biopsy and histopathological analysis at a regular physical check in April,2016.The patient received R-CO chemotherapy(rituximab,cyclophosphamide,and vincristine)and radiotherapy subsequently,with enteral nutritional treatment through 3-cavity nasogastric tube due to development of pyloric obstruction.To satisfy patient's strong desire of eating by himself,we performed surgery of exploratory laparotomy and Roux-en-Y gastric bypass(RGB)to relieve pylorus obstruction.Postoperatively,the patient resumed oral feeding,supplemented by nasogastric tube feeding at 1350-1550 Kcal daily.He is now 94 years old with fairly well nutrition and normal communication.The outcome of 4 year follow-up suggests that nutritional treatment and palliative medicine are important for improving prognosis and life-quality of very elderly patients with end-stage tumors apart from the effective chemotherapy,radiotherapy,and surgery. 展开更多
关键词 primary gastric lymphoma diffuse large b-cell lymphoma very elderly patient nutritional treatment palliative care
下载PDF
Disseminated soft tissue diffuse large B-cell lymphoma involving multiple abdominal wall muscles:A case report
7
作者 Chang-Hoon Lee So-Yeon Jeon +1 位作者 Ho-Young Yhim Jae-Yong Kwak 《World Journal of Clinical Cases》 SCIE 2021年第28期8557-8562,共6页
BACKGROUND Diffuse large B-cell lymphoma(DLBCL)is the most common subtype of non�Hodgkin lymphoma,and patients with DLBCL typically present rapidly growing masses.Lymphoma involving muscle is rare and accounts for onl... BACKGROUND Diffuse large B-cell lymphoma(DLBCL)is the most common subtype of non�Hodgkin lymphoma,and patients with DLBCL typically present rapidly growing masses.Lymphoma involving muscle is rare and accounts for only 5%;furthermore,multiple muscles and soft tissue involvement of DLBCL is unusual.Due to unusual clinical manifestation,accurate diagnosis could be delayed.CASE SUMMARY A 61-year-old man complained of swelling,pain and erythematous changes in the lower abdomen.Initially,soft tissue infection was suspected,however,skin lesion did not respond to antibiotics.18Fluoro-2-deoxy-D-glucose(18F-FDG)positron emission tomography-computed tomography demonstrated FDG uptake not only in the skin and subcutaneous tissue of the abdomen but also in the abdominal wall muscles,peritoneum,perineum,penis and testis.DLBCL was confirmed by biopsy of the abdominal wall muscle and subcutaneous tissue.After intensive treatment including chemotherapy with rituximab,cyclophosphamide,doxorubicin,vincristine and prednisolone,central nervous system prophylaxis(intrathecal injection of methotrexate,cytarabine and hydrocortisone)and orchiectomy,he underwent peripheral blood stem cell mobilization for an autologous hematopoietic stem cell transplantation.Despite intensive treatment,the disease progressed rapidly and the patient showed poor outcome(overall survival,9 mo;disease free survival,3 mo).CONCLUSION The first clinical manifestation of soft tissue DLBCL involving multiple muscles was similar to the infection of the soft tissue. 展开更多
关键词 primary extranodal diffuse large b-cell lymphoma Soft tissue lymphoma Disseminated muscles and soft tissue invasion Atypical presentation of diffuse large B�cell lymphoma Central nervous system relapse Case report
下载PDF
Primary gastric non-Hodgkin lymphomas:Recent advances regarding disease pathogenesis and treatment 被引量:6
8
作者 Michael D Diamantidis Maria Papaioannou Evdoxia Hatjiharissi 《World Journal of Gastroenterology》 SCIE CAS 2021年第35期5932-5945,共14页
Primary gastric lymphomas(PGLs)are distinct lymphoproliferative neoplasms described as heterogeneous entities clinically and molecularly.Their main histological types are diffuse large B-cell lymphoma(DLBCL)or mucosaa... Primary gastric lymphomas(PGLs)are distinct lymphoproliferative neoplasms described as heterogeneous entities clinically and molecularly.Their main histological types are diffuse large B-cell lymphoma(DLBCL)or mucosaassociated lymphoma tissue.PGL has been one of the main fields of clinical research of our group in recent years.Although gastric DLBCLs are frequent,sufficient data to guide optimal care are scarce.Until today,a multidisciplinary approach has been applied,including chemotherapy,surgery,radiotherapy or a combination of these treatments.In this minireview article,we provide an overview of the clinical manifestations,diagnosis and staging of these diseases,along with their molecular pathogenesis and the most important related clinical published series.We then discuss the scientific gaps,perils and pitfalls that exist regarding the aforementioned studies,in parallel with the unmet need for future research and comment on the proper methodology for such retrospective studies.Aiming to fill this gap,we retrospectively evaluated the trends in clinical presentation,management and outcome among 165 patients with DLBCL PGL who were seen in our institutions in 1980-2014.The study cohort was divided into two subgroups,comparing the main 2 therapeutic options[cyclophosphamide doxorubicin vincristine prednisone(CHOP)vs rituximab-CHOP(R-CHOP)].A better outcome with immunochemotherapy(R-CHOP)was observed.In the next 2 mo,we will present the update of our study with the same basic conclusion. 展开更多
关键词 primary gastric lymphoma Extranodal non-Hodgkin’s lymphoma Diffuse large b-cell lymphoma Mucosa-associated lymphoid tissue IMMUNOCHEMOTHERAPY Rituximab-cyclophosphamide doxorubicin vincristine prednisone
下载PDF
Primary colonic lymphoma:An incidental finding in a patient with a gallstone attack
9
作者 Silvia Gigli Valeria Buonocore +6 位作者 Flavio Barchetti Marianna Glorioso Martina Di Brino Pietro Guerrisi Chiara Buonocore Francesco Giova-gnorio Guglielmo Giraldi 《World Journal of Clinical Cases》 SCIE 2014年第5期146-150,共5页
We report a case of primary colonic lymphoma incidentally diagnosed in a patient presenting a gallbladder attack making particular attention on the diagnostic findings at ultrasound(US) and total body computed tomogra... We report a case of primary colonic lymphoma incidentally diagnosed in a patient presenting a gallbladder attack making particular attention on the diagnostic findings at ultrasound(US) and total body computed tomography(CT) exams that allowed us to make the correct final diagnosis.A 85-year-old Caucasian male patient was referred to our department due to acute pain at the upper right quadrant,spreaded to the right shoulder blade.Patient had nausea and mild fever and Murphy's maneuver was positive.At physical examination a large bulky mass was found in the right flank.Patient underwent to US exam that detected a big stone in the lumen of the gallbladder and in correspon-dence of the palpable mass,an extended concentric thickening of the colic wall.CT scan was performed and confirmed a widespread and concentric thickening of the wall of the ascending colon and cecum.In addition,revealed signs of microperforation of the colic wall.Numerous large lymphadenopathies were found in the abdominal,pelvic and thoracic cavity and there was a condition of splenomegaly,with some ischemic outcomes in the context of the spleen.No metastasis in the parenchimatous organs were found.These imaging findings suggest us the diagnosis of lymphoma.Patient underwent to surgery,and right hemicolectomy and cholecystectomy was performed.Histological examination confirmed our diagnosis,revealing a diffuse large B-cell lymphoma.The patient underwent to Cyclophosphamide,Hydroxydaunorubicin,Oncovin,Prednisone chemotherapy showing only a partial regression of the lymphadenopathies,being in advanced stage at the time of diagnosis. 展开更多
关键词 primary COLONIC lymphoma Gastrointestinal lymphoma Diffuse large b-cell lymphoma GALLSTONE ATTACK Computed tomography
下载PDF
Primary central nervous system lymphoma presenting as a single choroidal lesion mimicking metastasis:A case report
10
作者 Hee Ryeong Jang Kyu-Hyoung Lim Kyungyul Lee 《World Journal of Clinical Cases》 SCIE 2022年第4期1291-1295,共5页
BACKGROUND Primary choroidal lymphoma is usually an indolent B-cell lymphoma and rarely progresses to extraocular sites.Herein,we report a case of primary choroidal lymphoma diagnosed as diffuse large B-cell lymphoma(... BACKGROUND Primary choroidal lymphoma is usually an indolent B-cell lymphoma and rarely progresses to extraocular sites.Herein,we report a case of primary choroidal lymphoma diagnosed as diffuse large B-cell lymphoma(DLBL),which progressed to the brain parenchyma after 4 mo.CASE SUMMARY A 78-year-old man presented with diminution of vision in his right eye.A choroidal lesion suspected of metastatic lesion was observed in the right eye by ophthalmologic examination.To discover the primary tumor,imaging investigations were performed but no malignant lesion was detected.After 4 mo,the patient returned to the clinic presenting with neurological symptoms.Brain magnetic resonance imaging revealed an abnormal contrast-enhancing mass in the left cerebellum.A stereotactic biopsy was performed,and DLBL was confirmed.The patient received the high dose methotrexate-based chemotherapy and he achieved complete remission.CONCLUSION Primary choroidal lymphoma is usually known to have a benign clinical course without systemic involvement.We present a rare case of primary choroidal lymphoma diagnosed as DLBL that progressed to the brain parenchyma within months. 展开更多
关键词 primary choroidal lymphoma Diffuse large b-cell lymphoma primary central nervous system lymphoma Case report
下载PDF
Pathology Verified Concomitant Papillary Thyroid Carcinoma in the Sonographically Suspected Thyroid Lymphoma:A Case Report
11
作者 Qiong Wu Yu-xin Jiang +7 位作者 Jun-chao Guo Yu Xiao Xiao Yang Rui-na Zhao Xing-jian Lai Shen-ling Zhu Xiao-yan Zhang Bo Zhang 《Chinese Medical Sciences Journal》 CAS CSCD 2016年第1期54-58,共5页
PAPILLARY thyroid carcinoma (PTC) is the most common thyroid cancer and consists of nearly 80% of all cases of thyroid cancer.1 It is asso- ciated with the lowest level of malignancy and an excellent prognosis. Prim... PAPILLARY thyroid carcinoma (PTC) is the most common thyroid cancer and consists of nearly 80% of all cases of thyroid cancer.1 It is asso- ciated with the lowest level of malignancy and an excellent prognosis. Primary thyroid lymphoma (PTL) is a lymphomatous process which develops in the thyroid without involvement of primary lymphoid organs or distant metastases at diagnosis.2 It is a rare malignancy that accounts for 1%-5% of all thyroid malignancies and less than 2% of all extranodal lymphomas. The incidence of PTL is one or two cases per million.2' 3 It occurs frequently in elder woman, with a peak incidence in the sixth decade of life. 展开更多
关键词 ULTRASONOGRAPHY primary thyroid lymphoma papillary thyroid carcinoma COEXISTENCE diffuse large b-cell lymphoma
下载PDF
胸腺淋巴瘤18F-FDG PET/CT代谢参数与临床分期及病理分型的相关性研究 被引量:1
12
作者 潘越 杜磊 +6 位作者 翟雪 王观筠 徐晓丹 孟晓琳 刘家金 王瑞民 徐白萱 《解放军医学院学报》 CAS 北大核心 2023年第9期973-978,共6页
背景18F-FDG PET/CT利用图像融合技术,可显示功能代谢异常及结构的改变,但其在胸腺淋巴瘤鉴别诊断、分期和分型中的作用研究仍相对较少。目的探讨胸腺淋巴瘤的18F-FDG PET/CT代谢参数与其病理分型及临床分期的关系。方法选取2015年1月-2... 背景18F-FDG PET/CT利用图像融合技术,可显示功能代谢异常及结构的改变,但其在胸腺淋巴瘤鉴别诊断、分期和分型中的作用研究仍相对较少。目的探讨胸腺淋巴瘤的18F-FDG PET/CT代谢参数与其病理分型及临床分期的关系。方法选取2015年1月-2022年5月于解放军总医院一中心核医学科行PET/CT检查和病理学证实为胸腺淋巴瘤的患者,记录胸腺淋巴瘤病灶最大标准摄取值(maximum standard uptake value,SUVmax)、平均标准摄取值(mean standard uptake value,SUVmean)、代谢体积(metabolic tumor volume,MTV)、病灶糖酵解总量(total lesion glycolysis,TLG)和肿瘤-正常肝组织标准摄取值比值(tumor-to-normal liver standard uptake value ratio,SUVR)。以淋巴结和结外器官受累结果进行Ann Arbor分期,并根据主要病理类型进行分组。对18F-FDG PET/CT代谢参数与临床病理分型、分期的相关性进行分析。结果共计85例患者纳入研究,男性46例、女性39例,年龄(30.34±14.48)岁。其中原发性纵隔大B细胞淋巴瘤(primary mediastinal large B-cell lymphoma,PMBCL)35例,结节硬化型霍奇金淋巴瘤(nodular sclerosis Hodgkin lymphoma,NSHL)29例,T淋巴母细胞淋巴瘤(T-cell lymphoblastic lymphoma,T-LBL)19例。Ann Arbor分期:Ⅰ期2例,Ⅱ期29例,Ⅲ期10例,Ⅳ期44例。PMBCL、NSHL、T-LBL三组间各项代谢参数的差异均有统计学意义(P<0.05)。不同Ann Arbor分期间各代谢参数差异均有统计学意义(P<0.05)。胸腺淋巴瘤Ann Arbor分期与各项代谢参数均呈正相关(TLG:rs=0.494,P<0.01;MTV:rs=0.469,P<0.01;SUVR:rs=0.378,P<0.01;SUVmax:rs=0.296,P=0.006;SUVmean:rs=0.273,P=0.012)。结论不同病理类型胸腺淋巴瘤的18F-FDG PET/CT代谢参数存在一定差异,代谢参数TLG、MTV、SUVR与胸腺淋巴瘤Ann Arbor分期中度相关,可为临床制定治疗计划提供参考。 展开更多
关键词 胸腺淋巴瘤 正电子发射断层成像/计算机断层成像 代谢参数 纵隔大B细胞淋巴瘤 霍奇金淋巴瘤
下载PDF
56例伴纵隔大包块淋巴瘤患者的临床特征及预后分析 被引量:1
13
作者 于慧 王莉 +6 位作者 朱华渊 吴微 梁金花 尹华 范磊 李建勇 徐卫 《中国实验血液学杂志》 CAS CSCD 北大核心 2020年第2期495-499,共5页
目的:分析伴纵隔大包块淋巴瘤患者的发病情况、临床表现、治疗效果及预后。方法:回顾性分析2007年2月至2018年1月诊治的56例初诊伴有纵隔大包块患者的临床资料,包括临床特征、分型、分期、疗效及预后。结果:56例患者中,男性25例(45%),女... 目的:分析伴纵隔大包块淋巴瘤患者的发病情况、临床表现、治疗效果及预后。方法:回顾性分析2007年2月至2018年1月诊治的56例初诊伴有纵隔大包块患者的临床资料,包括临床特征、分型、分期、疗效及预后。结果:56例患者中,男性25例(45%),女性31例(55%),中位年龄31(17-72)岁。其中≤40岁患者48例(86%)。按病理分型,其中弥漫大B细胞淋巴瘤非特指型(DLBCL-NOS)9例(16.1%),原发纵隔大B细胞淋巴瘤(PMBCL)26例(46.4%),经典型霍奇金淋巴瘤(c HL)17例(30.4%),纵隔灰区淋巴瘤(MGZL)4例(7.1%)。所有患者均采用化疗或化学免疫治疗,中位随访时间54.5(11-149)个月。c HL组中联合受累野放疗(IFRT)10例,完全缓解(CR)10例(58.8%),部分缓解(PR)2例(11.8%),疾病进展(PD)5例(29.4%),治疗过程中有6例患者出现复发/难治而接受自体造血干细胞移植(auto-HSCT)。c HL组1年总生存率(OS)为94.1%,2年OS率为88.2%,5年OS率为67.2%。MGZL组中,联合IFRT 3例,auto-HSCT 1例,CR 2例(50%),PD 2例(50%)。MGZL组1年及2年OS率均为66.7%,5年OS率33.3%。PMBCL组中,联合IFRT 8例,auto-HSCT 7例,CR 22例(84.0%),PR 2例(8.0%),疾病稳定(SD)1例(4.0%),PD 1例(4.0%)。PMBCL组1年及2年OS率均为100%,5年OS率为95.7%。DLBCL-NOS组中,联合IFRT 3例,auto-HSCT 2例,CR 4例(44.5%),PR 2例(22.2%),疾病稳定(SD)1例(11.1%),PD 2例(22.2%)。DLBCL-NOS组1年OS率100%,2年及5年OS率均为77.8%。4组间OS率存在显著性差异(P<0.05),组间比较,PMBCL组生存期显著长于MGZL组(P<0.01)及c HL组(P<0.05),与DLBCL-NOS无显著性差异(P>0.05)。结论:纵隔肿物因其解剖部位独特,常表现为独特的临床特征。c HL、MGZL、PMBCL、DLBCL-NOS等几种原发或伴发纵隔大包块的B细胞起源的淋巴瘤,好发于年轻患者,其临床表现类似,但治疗效果差异显著。在现有治疗条件下,PMBCL的预后优于MGZL及c HL。 展开更多
关键词 经典型霍奇金淋巴瘤 原发纵隔灰区淋巴瘤 原发纵隔大B细胞淋巴瘤 弥漫大B细胞淋巴瘤非特指型 纵隔大包块
下载PDF
放化疗治疗原发纵隔大B细胞淋巴瘤的临床效果 被引量:3
14
作者 苏鹏飞 李颖璐 金哲 《中国实验血液学杂志》 CAS CSCD 北大核心 2015年第3期684-688,共5页
目的:探讨放化疗综合方案治疗原发纵隔大B细胞淋巴瘤(PMBCL)的临床效果。方法:回顾性分析34例行放化疗综合治疗(放化疗组)和28例仅行化疗治疗(对照组)的PMBCL患者的临床疗效、毒副反应以及远期生存情况。结果:放化疗组患者总有效率(OR)... 目的:探讨放化疗综合方案治疗原发纵隔大B细胞淋巴瘤(PMBCL)的临床效果。方法:回顾性分析34例行放化疗综合治疗(放化疗组)和28例仅行化疗治疗(对照组)的PMBCL患者的临床疗效、毒副反应以及远期生存情况。结果:放化疗组患者总有效率(OR)显著高于对照组,差异具有统计学意义(P<0.05);放化疗组患者血液毒性反应、黏膜炎及放射性皮炎发生率均显著高于对照组,差异具有统计学意义(P<0.05);放化疗组患者治疗后1年无进展生存率(PFS)显著高于对照组,治疗后3年局部控制率(LC)、PFS均显著高于对照组,治疗后5年LC、OS、PFS均显著高于对照组,差异具有统计学意义(P<0.05)。结论:放化疗综合方案治疗PMBCL疗效显著,远期无进展生存率高,可作为治疗PMBCL的优选方案,但需要注意放化疗并发症的预防。 展开更多
关键词 原发纵隔B细胞淋巴瘤 放化疗 临床疗效 生存情况
下载PDF
原发纵隔大B细胞淋巴瘤患者临床特征分析 被引量:3
15
作者 张树玲 吴斌 《中国医学前沿杂志(电子版)》 2015年第4期76-79,共4页
目的研究分析62例原发纵隔大B细胞淋巴瘤患者的临床特征。方法选取本院2013年1月至2014年3月收治的原发纵隔大B细胞淋巴瘤患者62例为研究对象,整理分析所有入选患者的临床资料、临床表现及病理特征,并进行随访,全面分析患者病情变化情... 目的研究分析62例原发纵隔大B细胞淋巴瘤患者的临床特征。方法选取本院2013年1月至2014年3月收治的原发纵隔大B细胞淋巴瘤患者62例为研究对象,整理分析所有入选患者的临床资料、临床表现及病理特征,并进行随访,全面分析患者病情变化情况。结果影响患者预后的不良因素有:患有上腔静脉综合征、未行放射治疗或未行靶向治疗、机体乳酸脱氢酶水平相对较高。治疗方式的不同亦影响患者的预后。62例患者经相应治疗后,完全缓解9例,部分缓解48例,无效5例。结论原发纵隔大B细胞淋巴瘤多发于男性,影像学表现以出现纵隔肿块且压迫周围组织器官为主。采用放射治疗+利妥昔单抗+CHOP方案治疗原发纵隔大B细胞淋巴瘤具有较明显的效果。 展开更多
关键词 原发纵隔 大B细胞淋巴瘤 临床特征
下载PDF
原发性纵隔大B细胞淋巴瘤临床病理分析并文献复习
16
作者 邵云 张博 +6 位作者 张凤霞 崔淼 刘翠 许春伟 王怀涛 吴永芳 李晓兵 《临床与病理杂志》 CAS 2015年第5期849-853,共5页
目的:探讨原发性纵隔大B细胞淋巴瘤(primary mediastinal large B-cell lymphoma,PMBL)的临床病理学特点及诊断要点。方法:收集2010年9月~2014年12月病理确诊为PMBL的病例,对其对PMBL进行临床特点、病理形态学及免疫组织化学观察... 目的:探讨原发性纵隔大B细胞淋巴瘤(primary mediastinal large B-cell lymphoma,PMBL)的临床病理学特点及诊断要点。方法:收集2010年9月~2014年12月病理确诊为PMBL的病例,对其对PMBL进行临床特点、病理形态学及免疫组织化学观察分析,并复习相关文献。结果:3例PMBL2例为男性,1例为女性,3例均侵犯邻近器官,2例伴颈部或锁骨上淋巴结受累,1例椎体受累(C7-T4)。镜下见不同程度的纤维化,瘤细胞呈巢状或弥漫浸润,瘤细胞胞质空亮丰富,细胞核圆形或卵圆形,其中1例可见坏死。免疫组织化学均表达CD20、CD79a、CD23、bcl2、CD23,其中2例表达CD30,均不表达CD3、CD5。随访3例均生存,化疗后1例获得CR,2例获得PR。结论:纵隔原发弥漫大B细胞淋巴瘤很少见,形态变化多端,容易引起误诊。提高对PMBL的认识,对避免误诊是至关重要的。 展开更多
关键词 纵隔大B细胞性淋巴瘤 诊断 鉴别诊断 免疫组织化学
下载PDF
放化疗与单纯化疗对原发纵隔大B细胞淋巴瘤患者生存的影响比较 被引量:1
17
作者 范冰杰 常宇 +2 位作者 柳喜洋 张明智 张蕾 《肿瘤防治研究》 CAS CSCD 2022年第3期205-212,共8页
目的探讨原发纵隔大B细胞淋巴瘤(PMBCL)的预后影响因素,分析利妥昔单抗时代前后接受放化疗与单纯化疗对患者预后的影响。方法从SEER数据库中提取2001—2015年间确诊的PMBCL患者,SEER Stat软件计算PMBCL的发病率,Kaplan-Meier法和Cox回... 目的探讨原发纵隔大B细胞淋巴瘤(PMBCL)的预后影响因素,分析利妥昔单抗时代前后接受放化疗与单纯化疗对患者预后的影响。方法从SEER数据库中提取2001—2015年间确诊的PMBCL患者,SEER Stat软件计算PMBCL的发病率,Kaplan-Meier法和Cox回归模型分析各临床变量对预后的影响。结果排除信息不完整的患者外,共纳入635例PMBCL患者。多因素Cox回归分析结果显示,年龄、分期、化疗是OS和DSS的独立预后因素。Kaplan-Meier生存分析显示,2006—2015年接受单纯化疗患者的OS明显优于2001—2005年的患者(χ^(2)=10.002,P=0.002)。2001—2005年接受化疗联合放疗患者的OS优于接受单纯化疗的患者,两组患者的DSS未见明显差异。2006—2015年接受放化疗联合治疗患者的OS和DSS与接受单纯化疗患者无明显差异。结论利妥昔单抗的应用改善了原发纵隔大B细胞淋巴瘤患者的长期生存,2006—2015年中接受放化疗的患者与接受单纯化疗的患者预后相当。 展开更多
关键词 原发纵隔大B细胞淋巴瘤 放化疗 化疗 监测、流行病学和结果数据库 生存分析
下载PDF
A Case of Primary Central Nervous System Lymphoma with Ciliary Body Involvement 被引量:1
18
作者 Meng-Da Li Chan Zhao +1 位作者 Jun-Jie Ye Hai-Yan Xu 《Chinese Medical Journal》 SCIE CAS CSCD 2016年第10期1246-1248,共3页
INTRODUCTION Primary central nervous system lymphoma (PCNSL) is defined as lymphoma confined to the brain, eye, spinal cord, or leptomeninges. It constitutes approximately 3% of all brain tumors, and 2-3% of all cas... INTRODUCTION Primary central nervous system lymphoma (PCNSL) is defined as lymphoma confined to the brain, eye, spinal cord, or leptomeninges. It constitutes approximately 3% of all brain tumors, and 2-3% of all cases of non-Hodgkin lymphoma. Ocular involvement can be detected during clinical staging in about 20% of patients with PCNSL, with primary vitreous retinal lymphoma being the most common subtype. Uveal involvement of PCNSL is uncommon, and PCNSL with ciliary body involvement (CBL), to the best of our knowledge, has not been reported. 展开更多
关键词 Ciliary Body lymphoma Diffuse large b-cell lymphoma primary Central Nervous System lymphoma primary lntraocular lymphoma
原文传递
原发性纵隔大B细胞淋巴瘤分子诊疗进展 被引量:1
19
作者 袁婷 曹铮 冯晓莉 《肿瘤防治研究》 CAS CSCD 2020年第5期387-392,共6页
原发性纵隔大B细胞淋巴瘤(PMBL)具有独特的临床病理和生物学特点。研究发现其某些分子特征与结节性硬化霍奇金淋巴瘤(NSHL)相似。最近的研究不仅关注这两种肿瘤的共同生物学特点,确定了淋巴瘤形成的新的关键途径,还关注它们不同的突变... 原发性纵隔大B细胞淋巴瘤(PMBL)具有独特的临床病理和生物学特点。研究发现其某些分子特征与结节性硬化霍奇金淋巴瘤(NSHL)相似。最近的研究不仅关注这两种肿瘤的共同生物学特点,确定了淋巴瘤形成的新的关键途径,还关注它们不同的突变基因。虽然目前PMBL的标准治疗方法是化疗和放疗,但也提出了去除放疗以消除其长期毒副作用的方法。在PMBL中评估新的靶向药物的作用和影响,为研究小分子抑制剂和免疫检查点抑制剂等药物铺平了道路,并指明这些疾病的未来治疗方向应侧重于有效的新药与化疗相结合。 展开更多
关键词 原发性纵隔大B细胞淋巴瘤 JAK-STAT通路 NF-ΚB通路 免疫豁免 PD-1 PD-L1
下载PDF
16例原发纵膈大B细胞淋巴瘤患者临床特征及预后分析
20
作者 胡星 江慧 +5 位作者 薛磊 耿良权 胡茂贵 丁凯阳 郑昌成 童娟 《临床输血与检验》 CAS 2022年第6期773-777,共5页
目的回顾性分析16例原发纵膈大B细胞淋巴瘤(PMBCL)患者的临床特征、疗效评估、疾病进展的危险因素及其生存预后。方法回顾性分析中国科学技术大学附属第一医院(安徽省立医院)自2015年3月~2022年2月收治的16例PMBCL患者的临床资料,分析... 目的回顾性分析16例原发纵膈大B细胞淋巴瘤(PMBCL)患者的临床特征、疗效评估、疾病进展的危险因素及其生存预后。方法回顾性分析中国科学技术大学附属第一医院(安徽省立医院)自2015年3月~2022年2月收治的16例PMBCL患者的临床资料,分析患者的临床特征及预后特点,并对相关数据进行统计分析。结果16例PMBCL患者的中位总生存(OS)时间未达到,5年OS率为92.3%。中位无进展生存(PFS)时间为7(95%CI 6.5~15.5)个月,5年PFS为43.3%。至随访截止日期,16例患者中,1例失访,中位随访时间25(95%CI 4~70)个月,14例(93.3%)生存,其中8例持续完全缓解(CR),5例部分缓解(PR),总缓解率(ORR)为86.67%。4例难治复发患者,使用PD-1抑制剂ORR达75%。单因素预后分析表明Ann Arbor分期、B组症状、LDH水平、是否巨型包块、aa-IPI评分、PET-CT病灶SUV-max、Mum-1是否阳性、不同Ki-67水平均不是引起PMBCL疾病进展的危险因素。结论PMBCL患者初始治疗使用含有利妥昔单抗的化疗方案,可改善患者总生存,但PFS改善不佳,需要新的方案以期待达到治愈的目的。复发难治PMBCL可考虑使用以PD-1单抗为基础的治疗方案。 展开更多
关键词 原发纵膈大B细胞淋巴瘤 PD-1单抗 预后 临床特征
下载PDF
上一页 1 2 下一页 到第
使用帮助 返回顶部